News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Luis E. Raez: Our IASLC Latin American group meeting at ASCO24
Photo from Luis E. Raez/X
Jun 6, 2024, 01:02

Luis E. Raez: Our IASLC Latin American group meeting at ASCO24

Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post on X/Twitter:

”Our IASLC (The International Association for the Study of Lung Cancer) Latin American group meeting at ASCO24. Clarissa Mathias, Andres F. Cardona, Claudio Martin and many others preparing for LALCA24.”

Source: Luis E. Raez/X

Andres F. Cardona ASCO24 cancer Clarissa Mathias IASLC LALCA24 Luis E. Raez Memorial Cancer Institut OncoDaily Oncology The International Association for the Study of Lung Cancer
Special Coverage
Insight
Aug 15, 2025, 06:24
Harpreet Singh: New Era for ADCs in HER-2 + Metastatic Breast Cancer
Science
Aug 15, 2025, 06:18
Ramy Sedhom Shares Study on Inpatient Immunotherapy Outcomes
Science
Aug 15, 2025, 06:11
Miguel Bronchud: Can Use of Aprepitant During Chemotherapy Improve TNBC Outcomes?
Voices
Aug 15, 2025, 06:04
Lung Cancer in Africa: Gaps and Role of a Community of Practice - Move Against Cancer Africa
Voices
Aug 15, 2025, 05:56
Megan Burger: Huge Day for Cancer Care
Science
Aug 15, 2025, 05:47
Gerry Hanna Highlights a Study on Tumor Control and Immune Activation with Palliative Irradiation and ATR Inhibition
Blog Posts
Aug 15, 2025, 05:46
Farina Arreguin: Systematic Review on Childhood Cancer Survivorship
Voices
Aug 15, 2025, 05:30
Andrew Pannu: Pharma Oncology Focuses on Backbones and Modality-Agnostic Combinations
Voices
Aug 15, 2025, 05:21
Tata Memorial Hospital Marks July with 52 Publications on Advancing Cancer Care
Science
Aug 15, 2025, 05:13
E. John Wherry: What's the Difference Between Trm and Exhausted CD8 T cells?
Science
Aug 15, 2025, 05:00
Indraneel Deshmukh: Important data in FLT-3 TKD Mutated AML
Drugs
Aug 15, 2025, 04:34
Repotrectinib (Augtyro) Patients Guide for 2025: Targeted Therapy for ROS1 and NTRK positive Tumors